psychedelics investing GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer
psychedelics investing GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences
pharmaceutical investing Greenstar Biosciences Signs Agreement to Acquire 100 Percent of Eleusian Biosciences Corp.
EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado